MHC ligands and peptide motifs: first listing

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Immunogenetics

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF00172063PMID 7890324
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peptide motifs of HLA-DR4/DR53 (DRB1*0405/DRB4*0101) molecules

  2005cited by this paper
• Peptide motifs of HLA-B38 and B39 molecules

  2004cited by this paper
• Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules

  2004cited by this paper
• Tum—mutation P35B generates the MHC-binding site of a new antigenic peptide

  2004cited by this paper
• Heat shock proteins transfer peptides during antigen processing and CTL priming

  2004cited by this paper
• Peptide motifs of HLA-B58, B60, B61, and B62 molecules

  2004cited by this paper
• Peptide motifs of HLA-B35 and-B37 molecules

  2004cited by this paper
• Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs

  2004cited by this paper
• The cell biology of antigen presentation.

  2002cited by this paper
• CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma

  1997cited by this paper
• Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behćet's disease.

  1995cited by this paper
• Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing

  1994cited by this paper
• Peptide selection by MHC-encoded TAP transporters.

  1994cited by this paper
• Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes.

  1994cited by this paper
• Nomenclature for Factors of the HLA System, 1994

  1994cited by this paper
• Origin, structure and motifs of naturally processed MHC class II ligands.

  1994cited by this paper
• Self peptides isolated from MHC glycoproteins of non-obese diabetic mice.

  1994cited by this paper
• Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb.

  1994cited by this paper
• Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.

  1994cited by this paper
• On the edge

  1994cited by this paper
• Structure of peptides associated with MHC class I molecules.

  1994cited by this paper
• Elicitation of specific cytotoxic T cells by immunization with malaria soluble synthetic polypeptides.

  1994cited by this paper
• Proteolytic Processing of Ovalbumin and β-galactosidase by the Proteasome to Yield Antigenic Peptides

  1994cited by this paper
• Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103).

  1994cited by this paper
• Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen.

  1994cited by this paper
• MHC class l/β2-microglobulin complexes associate with TAP transporters before peptide binding

  1994cited by this paper
• Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

  1994cited by this paper
• An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans

  1994cited by this paper
• Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins.

  1994cited by this paper
• Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide

  1994cited by this paper
• Interaction of in vitro- and in vivo-generated cytotoxic T cells with SV40 T antigen: analysis with synthetic peptides.

  1994cited by this paper
• Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones

  1994cited by this paper
• Recognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes

  1994cited by this paper
• Analysis of a naturally occurring HLA class I-restricted viral epitope.

  1994cited by this paper
• HLA-DR3 molecules can bind peptides carrying two alternative specific submotifs.

  1994cited by this paper
• Antigenic peptide binding by class I and class II histocompatibility proteins.

  1994cited by this paper
• A nonpolymorphic major histocompatibility complex class Ib molecule binds a large array of diverse self-peptides

  1994cited by this paper
• Peptide motifs of HLA-A1,-A11,-A31, and-A33 molecules

  1994cited by this paper
• Allele specificity of structural requirement for peptides bound to HLA- DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome

  1994cited by this paper
• Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain.

  1994cited by this paper
• Characterization of peptide binding to the murine MHC class I H-2Kk molecule. Sequencing of the bound peptides and direct binding of synthetic peptides to isolated class I molecules.

  1994cited by this paper
• Regulation of MHC class I transport by the molecular chaperone, calnexin (p88, IP90).

  1994cited by this paper
• A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

  1994cited by this paper
• Cells infected with Yersinia present an epitope to class I MHC-restricted CTL.

  1994cited by this paper
• Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

  1994cited by this paper
• An immunodominant Kb-restricted peptide from the p15E transmembrane protein of endogenous ecotropic murine leukemia virus (MuLV) AKR623 that restores susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes

  1994cited by this paper
• Human cytotoxic T lymphocytes stimulated by endogenously processed human papillomavirus type 11 E7 recognize a peptide containing a HLA-A2 (A*0201) motif.

  1994cited by this paper
• Nomenclature for factors of the HLA system, 1994.

  1994cited by this paper
• Measles virus hemagglutinin induces an Ld-restricted CD8+ cytotoxic T lymphocyte response to two specific epitopes.

  1994cited by this paper
• Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I-binding motif, explains MuLV-type specificity of MCF-directed cytotoxic T lymphocytes.

  1994cited by this paper
• Assembly, transport, and function of MHC class II molecules.

  1994cited by this paper
• Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.

  1994cited by this paper
• MHC class I/beta 2-microglobulin complexes associate with TAP transporters before peptide binding.

  1994cited by this paper
• Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to a yield antigenic peptides.

  1994cited by this paper
• Source of unique tumour antigens

  1994cited by this paper
• Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning

  1994cited by this paper
• Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.

  1994cited by this paper
• Identification of cytotoxic T cell epitopes on the VP3 and VP6 rotavirus proteins.

  1994cited by this paper
• Definition of specific peptide motifs for four major HLA-A alleles.

  1994cited by this paper
• Interaction of MHC class I molecules with the transporter associated with antigen processing.

  1994cited by this paper
• CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma

  1994cited by this paper
• Endogenous peptides with distinct amino acid anchor residue motifs bind to HLA-A1 and HLA-B8.

  1994cited by this paper
• Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays.

  1994cited by this paper
• Two tyrosinase nonapeptides recognized on HLA‐A2 melanomas by autologous cytolytic T lymphocytes

  1994cited by this paper
• A subset of HLA-B27 molecules contains peptides much longer than nonamers.

  1994cited by this paper
• Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy.

  1994cited by this paper
• Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401.

  1994cited by this paper
• Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

  1994cited by this paper
• Sequence features that correlate with MHC restriction.

  1994cited by this paper
• Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.

  1994cited by this paper
• Direct sequence identification and kinetic analysis of an MHC class I-restricted Listeria monocytogenes CTL epitope.

  1994cited by this paper
• Interaction of In Vitro‐ and In Vivo‐Generated Cytotoxic T Cells with SV40 T Antigen: Analysis with Synthetic Peptides

  1994cited by this paper
• Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.

  1994cited by this paper
• Defining rules for the peptide-MHC class II interaction.

  1994cited by this paper
• Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope

  1994cited by this paper
• An intracisternal A‐particle sequence codes for an antigen recognized by syngeneic cytolytic T lymphocytes on a mouse spontaneous leukemia

  1994cited by this paper
• Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein

  1993cited by this paper
• Mass spectrometric analysis of peptides associated with the human class I MHC molecules HLA-A2.1 and HLA-B7 and identification of structural features that determine binding.

  1993cited by this paper
• HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions.

  1993cited by this paper
• Antigen processing. Peptides and the proteasome.

  1993cited by this paper
• Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides.

  1993cited by this paper
• Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1

  1993cited by this paper
• Naturally processed HLA class I bound peptides from c-myc-transfected cells reveal allele-specific motifs.

  1993cited by this paper
• Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein

  1993cited by this paper
• A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides

  1993cited by this paper
• Allele-specific peptide ligand motifs of HLA-C molecules.

  1993cited by this paper
• An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV‐1 envelope glycoprotein

  1993cited by this paper
• The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

  1993cited by this paper
• H-2Dd exploits a four residue peptide binding motif

  1993cited by this paper
• A ubiquitous protein is the source of naturally occurring peptides that are recognized by a CD8+ T-cell clone.

  1993cited by this paper
• Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide

  1993cited by this paper
• Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells

  1993cited by this paper
• HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.

  1993cited by this paper
• Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling.

  1993cited by this paper
• Peptides and the proteasome

  1993cited by this paper
• HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis

  1993cited by this paper
• Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes.

  1993cited by this paper
• Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules.

  1993cited by this paper
• Qa-2 molecules are peptide receptors of higher stringency than ordinary class I molecules

  1993cited by this paper
• A prominent natural H-2 Kd ligand is derived from protein tyrosine kinase JAK1.

  1993cited by this paper

• Association of human leukocyte antigen B genotypes with COVID-19 severity in Egyptian patients

  2026cites this paper
• Improving peptide vaccine manufacturability without sacrificing immunogenicity: substitution of methionine and cysteine with oxidation-resistant isosteres

  2026cites this paper
• Categorical identity signatures can reduce host error rates during brood parasitism.

  2026cites this paper
• Dynamical network analysis reveals long-range residue couplings at the pMHC interface underlying enhanced immunogenicity

  2026cites this paper
• Strategies for neoantigen screening and immunogenicity validation in cancer immunotherapy (Review)

  2025cites this paper
• Norway rat hepacivirus resembles hepatitis C virus in terms of intra-host evolution and escape from neutralizing antibodies.

  2025cites this paper
• Mimicry in the Bite: Shared Sequences Between Aedes aegypti Salivary Proteins and Human Proteins

  2025cites this paper
• Proteasome-derived peptides: separating the trash from the recycling.

  2025cites this paper
• Epitope-Based Vaccines: The Next Generation of Promising Vaccines Against Bacterial Infection

  2025cites this paper
• Anti-amyloid β hydrophobic peptides in Alzheimer’s disease: biomarkers and therapeutic potential

  2025cites this paper
• Population-level toggling of T cell immune escape at human leukocyte antigen anchor residues in SARS-CoV-2 Spike proteins, in an ethnically diverse population region

  2025influential citation
• From Structure to Immunogenicity: Decoding Correlated Dynamics at the Peptide MHC interface to Understand TCR Recognition

  2025cites this paper
• Development of a multi-neoepitope vaccine targeting non-small cell lung cancer through reverse vaccinology and bioinformatics approaches

  2025cites this paper
• In vivo and in vitro recombinant systems of a novel variant demonstrate cross-reactive neutralization for the HCV model virus, Norway rat hepacivirus

  2025cites this paper
• Newly identified oncolytic VSV-GP-specific CD8+ T cell epitopes for monitoring of anti-viral immune responses in the BALB/c mouse model

  2025cites this paper
• Peptide selectivity of killer cell immunoglobulin-like receptors differs with allotypic variation in HLA class I.

  2025cites this paper
• PIRCHE-II Risk and Acceptable Mismatch Profile Analysis in Solid Organ Transplantation.

  2024cites this paper
• The electrostatic landscape of MHC-peptide binding revealed using inception networks.

  2024cites this paper
• Identification and relative abundance of naturally presented and cross-reactive influenza A virus MHC class I-restricted T cell epitopes

  2024cites this paper
• An Efficient Approach to the Accurate Prediction of Mutational Effects in Antigen Binding to the MHC1

  2024cites this paper
• Transfer Learning for T-Cell Response Prediction

  2024cites this paper
• Integrated analysis of single-cell and bulk RNA sequencing to construct a CD8+ T cell-related immune gene signature in pancreatic cancer

  2024cites this paper
• Immunoproteomic discovery of Mycobacterium bovis antigens, including the surface lipoprotein Mpt83 as a T cell antigen useful for vaccine development.

  2024cites this paper
• Towards designing improved cancer immunotherapy targets with a peptide-MHC-I presentation model, HLApollo

  2024cites this paper
• Immunoinformatics Approach to Design a Multi-Epitope Nanovaccine against Leishmania Parasite: Elicitation of Cellular Immune Responses

  2023cites this paper
• Peptide-based vaccine for cancer therapies

  2023cites this paper
• Prediction and validation of murine MHC class I epitopes of the recombinant virus VSV-GP

  2023influential citation
• Pathways of MHC I cross-presentation of exogenous antigens.

  2023cites this paper
• Immunogenic self-peptides - the great unknowns in autoimmunity: Identifying T-cell epitopes driving the autoimmune response in autoimmune diseases

  2023cites this paper
• Tyrosinase-Related Protein2 Peptide with Replacement of N-Terminus Residue by Cysteine Binds to H-2Kb and Induces Antigen-Specific Cytotoxic T Lymphocytes after Conjugation with CpG-DNA.

  2023cites this paper
• Precision neoantigen discovery using large-scale immunopeptidomes and composite modeling of MHC peptide presentation.

  2023cites this paper
• Thioamide Analogues of MHC I Antigen Peptides.

  2023cites this paper
• A New Strategy for Mapping Epitopes of LACK and PEPCK Proteins of Leishmania amazonensis Specific for Major Histocompatibility Complex Class I

  2023cites this paper
• Autoimmune susceptible HLA class II motifs facilitate the presentation of modified neoepitopes to potentially autoreactive T cells.

  2023cites this paper
• Molecular insights into the HLA‐B35 molecules' classification associated with HIV control

  2023cites this paper
• Crystal Structure of a Classical MHC Class I Molecule in Dogs; Comparison of DLA-88*0 and DLA-88*5 Category Molecules

  2023cites this paper
• Brain Hydrophobic Peptides Antagonists of Neurotoxic Amyloid β Peptide Monomers/Oligomers–Protein Interactions

  2023cites this paper
• A guide to current methodology and usage of reverse vaccinology towards in silico vaccine discovery.

  2023cites this paper
• Molecular mimicry and cancer vaccine development

  2023cites this paper
• Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response

  2023cites this paper
• Genetic variants affecting chemical mediated skin immunotoxicity

  2022cites this paper
• HLApollo: A superior transformer model for pan-allelic peptide-MHC-I presentation prediction, with diverse negative coverage, deconvolution and protein language features

  2022cites this paper
• Molecular Characterization of MHC Class I Alpha 1 and 2 Domains in Asian Seabass (Lates calcarifer)

  2022cites this paper
• Occupational health effect of TCE exposure: Experiment evidence of gene-environment interaction in hypersensitivity reaction.

  2022cites this paper
• In silico design and evaluation of a multi-epitope and multi-antigenic African swine fever vaccine

  2022cites this paper
• Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine

  2022cites this paper
• Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy

  2022cites this paper
• Human T cells recognize HLA-DP–bound peptides in two orientations

  2022cites this paper
• Long‐term SARS‐CoV‐2‐specific and cross‐reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology

  2022cites this paper
• West Nile virus–associated HLA‐DRB1 alleles in the Greek population: A structural perspective

  2022cites this paper
• In Silico Prediction And Evaluation of Human Parainfluenza Virus-3 CD4+ T Cell Epitopes.

  2022cites this paper
• Trial of cytotoxic T cell induction in mice as an ex vivo model of paraneoplastic neurologic syndrome with anti‐Hu antibodies

  2022cites this paper
• Can T-cell and B-cell excision circles predict development of inhibitors in pediatric hemophilia A?

  2022cites this paper
• Next Generation Sequencing Identifies the HLA-DQA1*03:03 Allele in the Type 1 Diabetes Risk-Associated HLA-DQ8 Serotype

  2021cites this paper
• Identification of mouse helper epitopes for WT1-specific CD4+ T cells

  2021cites this paper
• Antigen Processing, Presentation, and Tolerance: Role in Autoimmune Skin Diseases.

  2021cites this paper
• MS-Based HLA-II Peptidomics Combined With Multiomics Will Aid the Development of Future Immunotherapies

  2021cites this paper
• CD4+ T cells in the lungs of acute sarcoidosis patients recognize an Aspergillus nidulans epitope

  2021cites this paper
• Electrophysiological recordings from the olfactory epithelium and human brain in response to stimulation with HLA related peptides.

  2021cites this paper
• The Structure of a Peptide-Loaded Shark MHC Class I Molecule Reveals Features of the Binding between β2-Microglobulin and H Chain Conserved in Evolution

  2021cites this paper
• Precision Neoantigen Discovery Using Large-scale Immunopeptidomes and Composite Modeling of MHC Peptide Presentation

  2021cites this paper
• Most Japanese individuals are genetically predisposed to recognize an immunogenic protein fragment shared between COVID-19 and common cold coronaviruses

  2021cites this paper
• Corona Viruses and Human Leukocyte Antigen (HLA) alleles

  2021cites this paper
• Identification and characterization of heteroclitic peptides in TCR-binding positions with improved HLA-binding efficacy

  2021cites this paper
• New Approaches to Vaccinology Made Possible by Advances in Next Generation Sequencing, Bioinformatics and Protein modeling.

  2021cites this paper
• Deciphering Human Leukocyte Antigen Susceptibility Maps From Immunopeptidomics Characterization in Oncology and Infections

  2021cites this paper
• Genetic markers for psoriatic arthritis among patients with psoriasis. Part II: HLA genes

  2021influential citation
• Antigens

  2021cites this paper
• Influenza Antigens NP and M2 Confer Cross Protection to BALB/c Mice against Lethal Challenge with H1N1, Pandemic H1N1 or H5N1 Influenza A Viruses

  2021influential citation
• Characterization of HLA‐A*33:03 epitopes via immunoprecipitation and LC‐MS/MS

  2021cites this paper
• MHC-Optimized Peptide Scaffold for Improved Antigen Presentation and Anti-Tumor Response

  2021cites this paper
• Structural Comparison Between MHC Classes I and II; in Evolution, a Class-II-Like Molecule Probably Came First

  2021cites this paper
• Epitope-Based Immunoinformatic Approach on Heat Shock 70 kDa Protein Complex of Cryptococcus neoformans var. grubii

  2021cites this paper
• System-Level Scenarios for the Elucidation of T Cell-Mediated Germinal Center B Cell Differentiation

  2021cites this paper
• Comparison of HLA ligand elution data and binding predictions reveals varying prediction performance for the multiple motifs recognized by HLA-DQ2.5

  2020cites this paper
• Immunopeptidomic Data Integration to Artificial Neural Networks Enhances Protein-Drug Immunogenicity Prediction

  2020cites this paper
• Expected immune recognition of COVID-19 virus by memory from earlier infections with common coronaviruses in a large part of the world population.

  2020cites this paper
• Bioinformatics analysis of NetF proteins for designing a multi-epitope vaccine against Clostridium perfringens infection.

  2020cites this paper
• An innovative approach for HLA typing, molecular tumor testing and the validation of tumor exclusive antigens

  2020cites this paper
• Specificity of the T Cell Response to Protein Biopharmaceuticals

  2020cites this paper
• Prediction, mapping and validation of tick glutathione S-transferase B-cell epitopes.

  2020cites this paper
• The SysteMHC Atlas: a Computational Pipeline, a Website, and a Data Repository for Immunopeptidomic Analyses.

  2020cites this paper
• Two unique HLA-A*0201 restricted peptides derived from cyclin E as immunotherapeutic targets in leukemia

  2020cites this paper
• Deimmunization of protein therapeutics – Recent advances in experimental and computational epitope prediction and deletion

  2020cites this paper
• Bioinformatics for Cancer Immunotherapy: Methods and Protocols

  2020cites this paper
• Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44

  2020cites this paper
• Tumor-Specific T Cell Activation in Malignant Brain Tumors

  2020cites this paper
• Diverse sensory cues for individual recognition

  2020cites this paper
• Comparison of HLA ligand elution data and binding predictions reveals varying prediction performance for the multiple motifs recognized by HLA‐DQ2.5

  2020cites this paper
• Bioinformatics analysis of HPV-68 E6 and E7 oncoproteins for designing a therapeutic epitope vaccine against HPV infection.

  2020cites this paper
• Peptide vaccination directed against IDO1-expressing immune cells elicits CD8+ and CD4+ T-cell-mediated antitumor immunity and enhanced anti-PD1 responses

  2020cites this paper
• Expected immune recognition of COVID-19 virus by memory from earlier infections with common coronaviruses in a large part of the world population

  2020cites this paper
• Optimizing T‐cell receptor avidity with somatic hypermutation

  2019influential citation
• Generation and Utilization of In Vitro Models of Dendritic Cells for the Study of Dendritic Cell Biology

  2019cites this paper
• Modern Developments in Short Peptide Viral Vaccine Design

  2019cites this paper
• Potentiating Antigen-Specific Antibody Production with Peptides Obtained from In Silico Screening for High-Affinity against MHC-II

  2019cites this paper
• Key Features Relevant to Select Antigens and TCR From the MHC-Mismatched Repertoire to Treat Cancer

  2019cites this paper
• CRYSTAL STRUCTURE OF BAT MHC CLASS I PTAL-N*01:01 FOR 2.7 ANGSTROM

  2019cites this paper
• HLA associations in inflammatory arthritis: emerging mechanisms and clinical implications

  2019cites this paper
• Structure and Peptidome of the Bat MHC Class I Molecule Reveal a Novel Mechanism Leading to High-Affinity Peptide Binding

  2019cites this paper